Share on LinkedInShare on LinkedIn

ARTICLE · 01 SEPTEMBER 2021

Inventiveness Of Chinese Second Medical Use Patent: A Study From Top 10 Exemplary Invalidation Case

Second medical use of a known compound is an important invention to the pharmaceutical industry.

ChinaIntellectual Property

Second medical use of a known compound is an important invention to the pharmaceutical industry. However, due to the strict standard of examination for pharmaceutical patents in China, a large number of second medical use patent applications were rejected by the CNIPA. Although a few second medical use applications survived from the examination and were granted as patents in China, they were frequently challenged and most of them were declared invalid in the end. There were sayings by the pharmaceutical industry that Viagra second medical use patent was probably the only one that survived patent challenge in China.

Nevertheless, in the past two years, the CNIPA seemed to gradually easing the examination standard for pharma patent applications. In particular, the second medical use patent owned by the University of Bordeaux survived from a round of patent challenge in 2020, and this decision was selected by the CNIPA as one of TOP 10 exemplary Invalidation Cases for

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from